Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia in Relapse (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00374296
What this trial is testing

MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease

Who this might be right for
Myelogenous Leukemia, AcuteMyelodysplastic Syndromes
Mirati Therapeutics Inc. 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755202
What this trial is testing

Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory Leukemia

Who this might be right for
Acute Myeloid LeukemiaAML With FLT3 Mutation
Florian Kuchenbauer 20
Testing effectiveness (Phase 2)UnknownNCT04541277
What this trial is testing

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia, in Relapsed or RefractoryAcute Myeloid Leukemia, Elderly, UnfitAcute Myeloid Leukemia With Positive Minimal Residual Disease
Chinese PLA General Hospital 55
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Testing effectiveness (Phase 2)UnknownNCT01513603
What this trial is testing

Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic LymphomaBurkitts Leukemia/Lymphoma+1 more
New York Medical College 50
Testing effectiveness (Phase 2)Study completedNCT00354146
What this trial is testing

Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.

Who this might be right for
Leukemia, Nonlymphocytic, Acute
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 252
Early research (Phase 1)Study completedNCT03081780
What this trial is testing

Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML

Who this might be right for
Refractory Acute Myelogenous LeukemiaRelapsed Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 6
Testing effectiveness (Phase 2)Study completedNCT00620321
What this trial is testing

LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Eli Lilly and Company 24
Early research (Phase 1)Study completedNCT00002693
What this trial is testing

Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia

Who this might be right for
LeukemiaNeutropenia
Mayo Clinic
Early research (Phase 1)Study completedNCT04926285
What this trial is testing

Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Relapsed or Refractory Hematologic Malignancies
University of Illinois at Chicago 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07486726
What this trial is testing

Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)Relapse Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia (AML)
Shanghai Jiao Tong University School of Medicine 112
Early research (Phase 1)UnknownNCT02859948
What this trial is testing

SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT00512252
What this trial is testing

AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 52
Early research (Phase 1)Looking for participantsNCT06017258
What this trial is testing

CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Who this might be right for
Refractory Acute Myeloid LeukemiaRelapsed Acute Myeloid LeukemiaAcute Myeloid Leukemia+2 more
Memorial Sloan Kettering Cancer Center 15
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00667927
What this trial is testing

Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia
St. Jude Children's Research Hospital 17
Testing effectiveness (Phase 2)UnknownNCT03573596
What this trial is testing

Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment

Who this might be right for
CML, Relapsed
Amsterdam UMC, location VUmc 134
Not applicableApproved For MarketingNCT01869803
What this trial is testing

Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT01093586
What this trial is testing

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more
Case Comprehensive Cancer Center 14
Early research (Phase 1)Looking for participantsNCT03113643
What this trial is testing

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeBlastic Plasmacytoid Dendritic Cell Neoplasm
Dana-Farber Cancer Institute 72
Next Page